Company:
About
Ms. Foutty was appointed a director on August 30, 2024. She retired from Deloitte in September 2023 after more than 30 years with the company – most recently serving as executive chair of the board of Deloitte US and previously as CEO of Deloitte Consulting. During her time at Deloitte, Ms. Foutty helped Deloitte transform in response to market and technological disruptions, ultimately growing the business from $7 billion to $10 billion. She is a distinguished senior business leader, technologist, author, and frequent public speaker and currently serves on various not-for-profit boards, including Bright Pink, where she is Board Chair, Argonne National Labs, and The Chicago Network.
Personal Details
Title: Ms
Surname: Foutty
Known as: Janet
M/F: Female
Nationality: American
Country of Birth: United States of America
Language: English
Qualification: Not Available
Industry:
Qualifications & Experience
Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:
Other directorships (state)
(only entities turnover at least $5m p/a)
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Insight Enterprises | Board | Member | 30/08/2024 | |
| Insight Enterprises | Remuneration | Member | 30/08/2024 | |
| Insight Enterprises | Nominations & Governance | Member | 30/08/2024 |
Independence Questions
Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.